BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kang SS, Chun YK, Hur MH, Lee HK, Kim YJ, Hong SR, Lee JH, Lee SG, Park YK. Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma. Jpn J Cancer Res 2002;93:1123-8. [PMID: 12417042 DOI: 10.1111/j.1349-7006.2002.tb01214.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 85] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Hong R, Lim SC. 18F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma. World J Gastroenterol 2012; 18(2): 168-174 [PMID: 22253523 DOI: 10.3748/wjg.v18.i2.168] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
2 Yoo J, Seo BK, Park EK, Kwon M, Jeong H, Cho KR, Woo OH, Song SE, Cha J. Tumor stiffness measured by shear wave elastography correlates with tumor hypoxia as well as histologic biomarkers in breast cancer. Cancer Imaging 2020;20:85. [PMID: 33256820 DOI: 10.1186/s40644-020-00362-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Xintaropoulou C, Ward C, Wise A, Marston H, Turnbull A, Langdon SP. A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models. Oncotarget 2015;6:25677-95. [PMID: 26259240 DOI: 10.18632/oncotarget.4499] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 13.6] [Reference Citation Analysis]
4 Oh S, Kim H, Nam K, Shin I. Glut1 promotes cell proliferation, migration and invasion by regulating epidermal growth factor receptor and integrin signaling in triple-negative breast cancer cells. BMB Rep. 2017;50:132-137. [PMID: 27931517 DOI: 10.5483/BMBRep.2017.50.3.189] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 13.5] [Reference Citation Analysis]
5 Poulose N, Mills IG, Steele RE. The impact of transcription on metabolism in prostate and breast cancers. Endocr Relat Cancer 2018;25:R435-52. [PMID: 29760165 DOI: 10.1530/ERC-18-0048] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
6 Kannan S, Begoyan VV, Fedie JR, Xia S, Weseliński ŁJ, Tanasova M, Rao S. Metabolism-Driven High-Throughput Cancer Identification with GLUT5-Specific Molecular Probes. Biosensors (Basel) 2018;8:E39. [PMID: 29642606 DOI: 10.3390/bios8020039] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
7 Weiner MF, Miranda RN, Bardales RH, Mukunyadzi P, Baker SJ, Korourian S, De Las Casas LE. Diagnostic value of GLUT-1 immunoreactivity to distinguish benign from malignant cystic squamous lesions of the head and neck in fine-needle aspiration biopsy material. Diagn Cytopathol 2004;31:294-9. [DOI: 10.1002/dc.20127] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
8 Grabellus F, Sheu SY, Bachmann HS, Lehmann N, Otterbach F, Heusner TA, Antoch G, Bockisch A, Kimmig R, Schmid KW, Stahl AR. The XbaI G>T polymorphism of the glucose transporter 1 gene modulates 18F-FDG uptake and tumor aggressiveness in breast cancer. J Nucl Med 2010;51:1191-7. [PMID: 20679470 DOI: 10.2967/jnumed.110.075721] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
9 Vici P, Pizzuti L, Di Lauro L, Conti L, Mandoj C, Antenucci A, Digiesi G, Sergi D, Amodio A, Marchetti P, Sperati F, Valle M, Garofalo A, Vizza E, Corrado G, Vincenzoni C, Tomao F, Kayal R, Marsella A, Carosi M, Antoniani B, Giordano A, Maugeri-Saccà M, Barba M. Metabolic Determinants and Anthropometric Indicators Impact Clinical-pathological Features in Epithelial Ovarian Cancer Patients. J Cancer 2016;7:516-22. [PMID: 26958087 DOI: 10.7150/jca.13578] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
10 Fong MY, Zhou W, Liu L, Alontaga AY, Chandra M, Ashby J, Chow A, O'Connor ST, Li S, Chin AR, Somlo G, Palomares M, Li Z, Tremblay JR, Tsuyada A, Sun G, Reid MA, Wu X, Swiderski P, Ren X, Shi Y, Kong M, Zhong W, Chen Y, Wang SE. Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis. Nat Cell Biol 2015;17:183-94. [PMID: 25621950 DOI: 10.1038/ncb3094] [Cited by in Crossref: 544] [Cited by in F6Publishing: 534] [Article Influence: 90.7] [Reference Citation Analysis]
11 Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 2007;26:225-39. [DOI: 10.1007/s10555-007-9055-1] [Cited by in Crossref: 1406] [Cited by in F6Publishing: 1291] [Article Influence: 100.4] [Reference Citation Analysis]
12 Macheda ML, Rogers S, Best JD. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol. 2005;202:654-662. [PMID: 15389572 DOI: 10.1002/jcp.20166] [Cited by in Crossref: 739] [Cited by in F6Publishing: 701] [Article Influence: 46.2] [Reference Citation Analysis]
13 Sung JY, Kim GY, Lim SJ, Park YK, Kim YW. Expression of the GLUT1 glucose transporter and p53 in carcinomas of the pancreatobiliary tract. Pathol Res Pract. 2010;206:24-29. [PMID: 19819644 DOI: 10.1016/j.prp.2009.07.018] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
14 Rendic S, Guengerich FP. Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters. Curr Drug Metab 2010;11:4-84. [PMID: 20302566 DOI: 10.2174/138920010791110917] [Cited by in Crossref: 76] [Cited by in F6Publishing: 64] [Article Influence: 6.9] [Reference Citation Analysis]
15 Kuo S, Wu Y, Chen C, Tseng H, Chen D. Expression of Glucose Transporter-1 in Taiwanese Patients with Breast Carcinoma—A Preliminary Report. The Kaohsiung Journal of Medical Sciences 2006;22:339-45. [DOI: 10.1016/s1607-551x(09)70320-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
16 Young CD, Lewis AS, Rudolph MC, Ruehle MD, Jackman MR, Yun UJ, Ilkun O, Pereira R, Abel ED, Anderson SM. Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo. PLoS One. 2011;6:e23205. [PMID: 21826239 DOI: 10.1371/journal.pone.0023205] [Cited by in Crossref: 122] [Cited by in F6Publishing: 116] [Article Influence: 12.2] [Reference Citation Analysis]
17 Ozcan A, Shen SS, Zhai QJ, Truong LD. Expression of GLUT1 in primary renal tumors: morphologic and biologic implications. Am J Clin Pathol 2007;128:245-54. [PMID: 17638658 DOI: 10.1309/HV6NJVRQKK4QHM9F] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
18 Yang Y, Wolfram J, Boom K, Fang X, Shen H, Ferrari M. Hesperetin impairs glucose uptake and inhibits proliferation of breast cancer cells. Cell Biochem Funct 2013;31:374-9. [PMID: 23042260 DOI: 10.1002/cbf.2905] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 6.0] [Reference Citation Analysis]
19 Adams A, van Brussel AS, Vermeulen JF, Mali WP, van der Wall E, van Diest PJ, Elias SG. The potential of hypoxia markers as target for breast molecular imaging--a systematic review and meta-analysis of human marker expression. BMC Cancer 2013;13:538. [PMID: 24206539 DOI: 10.1186/1471-2407-13-538] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
20 Oh S, Kim H, Nam K, Shin I. Silencing of Glut1 induces chemoresistance via modulation of Akt/GSK-3β/β-catenin/survivin signaling pathway in breast cancer cells. Archives of Biochemistry and Biophysics 2017;636:110-22. [DOI: 10.1016/j.abb.2017.08.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
21 Li X, Luo H, Paul S, Tang T, Yuan G. Downregulation of the Expression of GLUT1 Plays a Role in Apoptosis Induced by Sodium Butyrate in HT-29 Cell Line. IJMS 2006;7:59-70. [DOI: 10.3390/i7020059] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
22 Thirabanjasak D, Basturk O, Altinel D, Cheng JD, Adsay NV. Is serous cystadenoma of the pancreas a model of clear-cell-associated angiogenesis and tumorigenesis? Pancreatology 2009;9:182-8. [PMID: 19077470 DOI: 10.1159/000178890] [Cited by in Crossref: 40] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
23 Kapoor S. Glucose transporter 1 (GLUT1) and its emerging role as a significant prognostic marker in systemic malignancies. Int J Colorectal Dis 2013;28:1317-8. [PMID: 23149615 DOI: 10.1007/s00384-012-1610-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
24 Garrido P, Morán J, Alonso A, González S, González C. 17β-estradiol activates glucose uptake via GLUT4 translocation and PI3K/Akt signaling pathway in MCF-7 cells. Endocrinology. 2013;154:1979-1989. [PMID: 23546602 DOI: 10.1210/en.2012-1558] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 5.9] [Reference Citation Analysis]
25 Sheeley MP, Andolino C, Kiesel VA, Teegarden D. Vitamin D regulation of energy metabolism in cancer. Br J Pharmacol 2021. [PMID: 33651382 DOI: 10.1111/bph.15424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Calaluce R, Gubin MM, Davis JW, Magee JD, Chen J, Kuwano Y, Gorospe M, Atasoy U. The RNA binding protein HuR differentially regulates unique subsets of mRNAs in estrogen receptor negative and estrogen receptor positive breast cancer. BMC Cancer 2010;10:126. [PMID: 20370918 DOI: 10.1186/1471-2407-10-126] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
27 Li CX, Sun JL, Gong ZC, Lin ZQ, Liu H. Prognostic value of GLUT-1 expression in oral squamous cell carcinoma: A prisma-compliant meta-analysis. Medicine (Baltimore) 2016;95:e5324. [PMID: 27828852 DOI: 10.1097/MD.0000000000005324] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
28 Wu Z, Wu J, Zhao Q, Fu S, Jin J. Emerging roles of aerobic glycolysis in breast cancer. Clin Transl Oncol 2020;22:631-46. [PMID: 31359335 DOI: 10.1007/s12094-019-02187-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 15.0] [Reference Citation Analysis]
29 Pankratz SL, Tan EY, Fine Y, Mercurio AM, Shaw LM. Insulin receptor substrate-2 regulates aerobic glycolysis in mouse mammary tumor cells via glucose transporter 1. J Biol Chem 2009;284:2031-7. [PMID: 19056742 DOI: 10.1074/jbc.M804776200] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 2.2] [Reference Citation Analysis]
30 Stackhouse BL, Williams H, Berry P, Russell G, Thompson P, Winter JL, Kute T. Measurement of glut-1 expression using tissue microarrays to determine a race specific prognostic marker for breast cancer. Breast Cancer Res Treat 2005;93:247-53. [PMID: 16228617 DOI: 10.1007/s10549-005-5158-y] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
31 Ozbudak IH, Shilo K, Tavora F, Rassaei N, Chu WS, Fukuoka J, Jen J, Travis WD, Franks TJ. Glucose transporter-1 in pulmonary neuroendocrine carcinomas: expression and survival analysis. Mod Pathol 2009;22:633-8. [PMID: 19234439 DOI: 10.1038/modpathol.2009.6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
32 Yan S, Wang Y, Chen M, Li G, Fan J. Deregulated SLC2A1 Promotes Tumor Cell Proliferation and Metastasis in Gastric Cancer. Int J Mol Sci 2015;16:16144-57. [PMID: 26193257 DOI: 10.3390/ijms160716144] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
33 Kumar S, Mokhtari RB, Oliveira ID, Islam S, Toledo SR, Yeger H, Baruchel S. Tumor dynamics in response to antiangiogenic therapy with oral metronomic topotecan and pazopanib in neuroblastoma xenografts. Transl Oncol 2013;6:493-503. [PMID: 23908692 DOI: 10.1593/tlo.13286] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
34 Koda M, Kanczuga-Koda L, Sulkowska M, Surmacz E, Sulkowski S. Relationships between hypoxia markers and the leptin system, estrogen receptors in human primary and metastatic breast cancer: effects of preoperative chemotherapy. BMC Cancer. 2010;10:320. [PMID: 20569445 DOI: 10.1186/1471-2407-10-320] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
35 Deng Y, Zou J, Deng T, Liu J. Clinicopathological and prognostic significance of GLUT1 in breast cancer: A meta-analysis. Medicine (Baltimore) 2018;97:e12961. [PMID: 30508885 DOI: 10.1097/MD.0000000000012961] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
36 Sereno M, Videira M, Wilhelm I, Krizbai IA, Brito MA. miRNAs in Health and Disease: A Focus on the Breast Cancer Metastatic Cascade towards the Brain. Cells 2020;9:E1790. [PMID: 32731349 DOI: 10.3390/cells9081790] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
37 Curcio C, Brugiapaglia S, Bulfamante S, Follia L, Cappello P, Novelli F. The Glycolytic Pathway as a Target for Novel Onco-Immunology Therapies in Pancreatic Cancer. Molecules 2021;26:1642. [PMID: 33804240 DOI: 10.3390/molecules26061642] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Chai YJ, Yi JW, Oh SW, Kim YA, Yi KH, Kim JH, Lee KE. Upregulation of SLC2 (GLUT) family genes is related to poor survival outcomes in papillary thyroid carcinoma: Analysis of data from The Cancer Genome Atlas. Surgery 2017;161:188-94. [DOI: 10.1016/j.surg.2016.04.050] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
39 Godoy A, Salazar K, Figueroa C, Smith GJ, de Los Angeles Garcia M, Nualart FJ. Nutritional channels in breast cancer. J Cell Mol Med 2009;13:3973-84. [PMID: 19602043 DOI: 10.1111/j.1582-4934.2008.00544.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
40 Favaro E, Lord S, Harris AL, Buffa FM. Gene expression and hypoxia in breast cancer. Genome Med 2011;3:55. [PMID: 21875443 DOI: 10.1186/gm271] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 5.7] [Reference Citation Analysis]
41 Kim S, Jung WH, Koo JS. The Expression of Glut-1, CAIX, and MCT4 in Mucinous Carcinoma. J Breast Cancer 2013;16:146-51. [PMID: 23843845 DOI: 10.4048/jbc.2013.16.2.146] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
42 Medina RA, Meneses AM, Vera JC, Guzman C, Nualart F, Astuya A, García MA, Kato S, Carvajal A, Pinto M, Owen GI. Estrogen and progesterone up-regulate glucose transporter expression in ZR-75-1 human breast cancer cells. Endocrinology 2003;144:4527-35. [PMID: 12960090 DOI: 10.1210/en.2003-0294] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.6] [Reference Citation Analysis]
43 Hussein YR, Bandyopadhyay S, Semaan A, Ahmed Q, Albashiti B, Jazaerly T, Nahleh Z, Ali-Fehmi R. Glut-1 Expression Correlates with Basal-like Breast Cancer. Transl Oncol 2011;4:321-7. [PMID: 22190995 DOI: 10.1593/tlo.11256] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 3.2] [Reference Citation Analysis]
44 Fujino M, Aishima S, Shindo K, Oda Y, Morimatsu K, Tsutsumi K, Otsuka T, Tanaka M, Oda Y. Expression of glucose transporter-1 is correlated with hypoxia-inducible factor 1α and malignant potential in pancreatic neuroendocrine tumors. Oncol Lett 2016;12:3337-43. [PMID: 27900001 DOI: 10.3892/ol.2016.5092] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
45 Carvalho KC, Cunha IW, Rocha RM, Ayala FR, Cajaíba MM, Begnami MD, Vilela RS, Paiva GR, Andrade RG, Soares FA. GLUT1 expression in malignant tumors and its use as an immunodiagnostic marker. Clinics (Sao Paulo) 2011;66:965-72. [PMID: 21808860 DOI: 10.1590/s1807-59322011000600008] [Cited by in Crossref: 115] [Cited by in F6Publishing: 73] [Article Influence: 12.8] [Reference Citation Analysis]
46 Jang SM, Han H, Jang KS, Jun YJ, Jang SH, Min KW, Chung MS, Paik SS. The Glycolytic Phenotype is Correlated with Aggressiveness and Poor Prognosis in Invasive Ductal Carcinomas. J Breast Cancer 2012;15:172-80. [PMID: 22807934 DOI: 10.4048/jbc.2012.15.2.172] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
47 Risha Y, Minic Z, Ghobadloo SM, Berezovski MV. The proteomic analysis of breast cell line exosomes reveals disease patterns and potential biomarkers. Sci Rep 2020;10:13572. [PMID: 32782317 DOI: 10.1038/s41598-020-70393-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
48 Shaw LM. The insulin receptor substrate (IRS) proteins: at the intersection of metabolism and cancer. Cell Cycle 2011;10:1750-6. [PMID: 21597332 DOI: 10.4161/cc.10.11.15824] [Cited by in Crossref: 79] [Cited by in F6Publishing: 76] [Article Influence: 7.9] [Reference Citation Analysis]
49 Agrawal S, Łuc M, Ziółkowski P, Agrawal AK, Pielka E, Walaszek K, Zduniak K, Woźniak M. Insulin-induced enhancement of MCF-7 breast cancer cell response to 5-fluorouracil and cyclophosphamide. Tumour Biol 2017;39:1010428317702901. [PMID: 28631569 DOI: 10.1177/1010428317702901] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
50 Treekoon J, Pewklang T, Chansaenpak K, Gorantla JN, Pengthaisong S, Lai RY, Ketudat-Cairns JR, Kamkaew A. Glucose conjugated aza-BODIPY for enhanced photodynamic cancer therapy. Org Biomol Chem 2021;19:5867-75. [PMID: 34124730 DOI: 10.1039/d1ob00400j] [Reference Citation Analysis]
51 Zhao ZX, Lu LW, Qiu J, Li QP, Xu F, Liu BJ, Dong JC, Gong WY. Glucose transporter-1 as an independent prognostic marker for cancer: a meta-analysis. Oncotarget 2018;9:2728-38. [PMID: 29416806 DOI: 10.18632/oncotarget.18964] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
52 Brauer HA, Makowski L, Hoadley KA, Casbas-Hernandez P, Lang LJ, Romàn-Pèrez E, D'Arcy M, Freemerman AJ, Perou CM, Troester MA. Impact of tumor microenvironment and epithelial phenotypes on metabolism in breast cancer. Clin Cancer Res 2013;19:571-85. [PMID: 23236214 DOI: 10.1158/1078-0432.CCR-12-2123] [Cited by in Crossref: 59] [Cited by in F6Publishing: 49] [Article Influence: 6.6] [Reference Citation Analysis]
53 Aboushousha T, Mamdouh S, Hamdy H, Helal N, Khorshed F, Safwat G, Seleem M. Immunohistochemical and Biochemical Expression Patterns of TTF-1, RAGE, GLUT-1 and SOX2 in HCV-Associated Hepatocellular Carcinomas. Asian Pac J Cancer Prev 2018;19:219-27. [PMID: 29373917 DOI: 10.22034/APJCP.2018.19.1.219] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
54 Omata W, Shibata H, Nagasawa M, Kojima I, Kikuchi H, Oshima Y, Hosaka K, Kubohara Y. Dictyostelium differentiation-inducing factor-1 induces glucose transporter 1 translocation and promotes glucose uptake in mammalian cells. FEBS J 2007;274:3392-404. [PMID: 17553062 DOI: 10.1111/j.1742-4658.2007.05872.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
55 Bao B, Azmi AS, Ali S, Ahmad A, Li Y, Banerjee S, Kong D, Sarkar FH. The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. Biochim Biophys Acta. 2012;1826:272-296. [PMID: 22579961 DOI: 10.1016/j.bbcan.2012.04.008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 80] [Article Influence: 4.2] [Reference Citation Analysis]
56 Peiró CHF, Perez MM, de Aquino GSA, Encinas JFA, Sousa LVA, da Veiga GL, Del Giglio A, Fonseca FLA, da Costa Aguiar Alves B. Diagnostic potential of hypoxia-induced genes in liquid biopsies of breast cancer patients. Sci Rep 2021;11:8724. [PMID: 33888756 DOI: 10.1038/s41598-021-87897-2] [Reference Citation Analysis]
57 Rakheja D, Khokhar S, Mitui M, Cost NG. Immunohistochemical expression of GLUT1 and its correlation with unfavorable histology and TP53 codon 72 polymorphism in Wilms tumors. Pediatr Dev Pathol 2012;15:286-92. [PMID: 22483234 DOI: 10.2350/12-01-1151-OA.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
58 Mori Y, Tsukinoki K, Yasuda M, Miyazawa M, Kaneko A, Watanabe Y. Glucose transporter type 1 expression are associated with poor prognosis in patients with salivary gland tumors. Oral Oncol. 2007;43:563-569. [PMID: 17071132 DOI: 10.1016/j.oraloncology.2006.06.006] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
59 Qian Y, Wang X, Chen X. Inhibitors of glucose transport and glycolysis as novel anticancer therapeutics. World J Transl Med 2014; 3(2): 37-57 [DOI: 10.5528/wjtm.v3.i2.37] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
60 Rathmell JC, Fox CJ, Plas DR, Hammerman PS, Cinalli RM, Thompson CB. Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol Cell Biol 2003;23:7315-28. [PMID: 14517300 DOI: 10.1128/MCB.23.20.7315-7328.2003] [Cited by in Crossref: 408] [Cited by in F6Publishing: 224] [Article Influence: 22.7] [Reference Citation Analysis]
61 Kumar P, Paknikar KM, Gajbhiye V. A robust pH-sensitive unimolecular dendritic nanocarrier that enables targeted anti-cancer drug delivery via GLUT transporters. Colloids and Surfaces B: Biointerfaces 2018;171:437-44. [DOI: 10.1016/j.colsurfb.2018.07.053] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
62 Lidgren A, Bergh A, Grankvist K, Rasmuson T, Ljungberg B. Glucose transporter-1 expression in renal cell carcinoma and its correlation with hypoxia inducible factor-1 alpha. BJU Int 2008;101:480-4. [PMID: 17922867 DOI: 10.1111/j.1464-410X.2007.07238.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 20] [Article Influence: 0.2] [Reference Citation Analysis]
63 Rivenzon-segal D, Boldin-adamsky S, Seger D, Seger R, Degani H. Glycolysis and glucose transporter 1 as markers of response to hormonal therapy in breast cancer. Int J Cancer 2003;107:177-82. [DOI: 10.1002/ijc.11387] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 2.9] [Reference Citation Analysis]
64 Venmar KT, Kimmel DW, Cliffel DE, Fingleton B. IL4 receptor α mediates enhanced glucose and glutamine metabolism to support breast cancer growth. Biochim Biophys Acta 2015;1853:1219-28. [PMID: 25746764 DOI: 10.1016/j.bbamcr.2015.02.020] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
65 Yu M, Yongzhi H, Chen S, Luo X, Lin Y, Zhou Y, Jin H, Hou B, Deng Y, Tu L, Jian Z. The prognostic value of GLUT1 in cancers: a systematic review and meta-analysis. Oncotarget 2017;8:43356-67. [PMID: 28498810 DOI: 10.18632/oncotarget.17445] [Cited by in Crossref: 56] [Cited by in F6Publishing: 53] [Article Influence: 18.7] [Reference Citation Analysis]
66 Alves WEFM, Bonatelli M, Dufloth R, Kerr LM, Carrara GFA, da Costa RFA, Scapulatempo-Neto C, Tiezzi D, da Costa Vieira RA, Pinheiro C. CAIX is a predictor of pathological complete response and is associated with higher survival in locally advanced breast cancer submitted to neoadjuvant chemotherapy. BMC Cancer 2019;19:1173. [PMID: 31795962 DOI: 10.1186/s12885-019-6353-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
67 Sharen G, Peng Y, Cheng H, Liu Y, Shi Y, Zhao J. Prognostic value of GLUT-1 expression in pancreatic cancer: results from 538 patients. Oncotarget 2017;8:19760-7. [PMID: 28178665 DOI: 10.18632/oncotarget.15035] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
68 Kim I, Kwon D, Lee D, Lee G, Yoon DS. Permselective glucose sensing with GLUT1-rich cancer cell membranes. Biosensors and Bioelectronics 2019;135:82-7. [DOI: 10.1016/j.bios.2019.04.007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
69 Yu M, Chen S, Hong W, Gu Y, Huang B, Lin Y, Zhou Y, Jin H, Deng Y, Tu L, Hou B, Jian Z. Prognostic role of glycolysis for cancer outcome: evidence from 86 studies. J Cancer Res Clin Oncol 2019;145:967-99. [DOI: 10.1007/s00432-019-02847-w] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 13.5] [Reference Citation Analysis]
70 Ganapathy V, Thangaraju M, Prasad PD. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther 2009;121:29-40. [PMID: 18992769 DOI: 10.1016/j.pharmthera.2008.09.005] [Cited by in Crossref: 465] [Cited by in F6Publishing: 425] [Article Influence: 35.8] [Reference Citation Analysis]
71 Shin E, Koo JS. Glucose Metabolism and Glucose Transporters in Breast Cancer. Front Cell Dev Biol 2021;9:728759. [PMID: 34552932 DOI: 10.3389/fcell.2021.728759] [Reference Citation Analysis]
72 Watanabe M, Abe N, Oshikiri Y, Stanbridge EJ, Kitagawa T. Selective growth inhibition by glycogen synthase kinase-3 inhibitors in tumorigenic HeLa hybrid cells is mediated through NF-κB-dependent GLUT3 expression. Oncogenesis. 2012;1:e21. [PMID: 23552737 DOI: 10.1038/oncsis.2012.21] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
73 Akhenblit PJ, Pagel MD. Recent Advances in Targeting Tumor Energy Metabolism with Tumor Acidosis as a Biomarker of Drug Efficacy. J Cancer Sci Ther 2016;8:20-9. [PMID: 26962408 DOI: 10.4172/1948-5956.1000382] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
74 Krzeslak A, Wojcik-Krowiranda K, Forma E, Jozwiak P, Romanowicz H, Bienkiewicz A, Brys M. Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers. Pathol Oncol Res. 2012;18:721-728. [PMID: 22270867 DOI: 10.1007/s12253-012-9500-5] [Cited by in Crossref: 141] [Cited by in F6Publishing: 145] [Article Influence: 15.7] [Reference Citation Analysis]
75 Mishra A, Srivastava A, Pateriya A, Tomar MS, Mishra AK, Shrivastava A. Metabolic reprograming confers tamoxifen resistance in breast cancer. Chem Biol Interact 2021;347:109602. [PMID: 34331906 DOI: 10.1016/j.cbi.2021.109602] [Reference Citation Analysis]
76 Zhang Y, Yang JM. Altered energy metabolism in cancer: a unique opportunity for therapeutic intervention. Cancer Biol Ther 2013;14:81-9. [PMID: 23192270 DOI: 10.4161/cbt.22958] [Cited by in Crossref: 73] [Cited by in F6Publishing: 73] [Article Influence: 8.1] [Reference Citation Analysis]
77 Li Y, Li H, Wang W, Yu X, Xu Q. LINC00346 regulates glycolysis by modulation of glucose transporter 1 in breast cancer cells. Mol Cell Probes 2020;54:101667. [PMID: 32946972 DOI: 10.1016/j.mcp.2020.101667] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
78 Chen X, Qian Y, Wu S. The Warburg effect: evolving interpretations of an established concept. Free Radic Biol Med 2015;79:253-63. [PMID: 25277420 DOI: 10.1016/j.freeradbiomed.2014.08.027] [Cited by in Crossref: 100] [Cited by in F6Publishing: 104] [Article Influence: 14.3] [Reference Citation Analysis]
79 Barron CC, Bilan PJ, Tsakiridis T, Tsiani E. Facilitative glucose transporters: Implications for cancer detection, prognosis and treatment. Metabolism. 2016;65:124-139. [PMID: 26773935 DOI: 10.1016/j.metabol.2015.10.007] [Cited by in Crossref: 179] [Cited by in F6Publishing: 172] [Article Influence: 29.8] [Reference Citation Analysis]
80 Jonathan RA, Wijffels KI, Peeters W, de Wilde PC, Marres HA, Merkx MA, Oosterwijk E, van der Kogel AJ, Kaanders JH. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON. Radiotherapy and Oncology 2006;79:288-97. [DOI: 10.1016/j.radonc.2006.04.008] [Cited by in Crossref: 78] [Cited by in F6Publishing: 68] [Article Influence: 5.2] [Reference Citation Analysis]
81 Ohba S, Fujii H, Ito S, Fujimaki M, Matsumoto F, Furukawa M, Yokoyama J, Kusunoki T, Ikeda K, Hino O. Overexpression of GLUT-1 in the invasion front is associated with depth of oral squamous cell carcinoma and prognosis. J Oral Pathol Med 2010;39:74-8. [PMID: 19709351 DOI: 10.1111/j.1600-0714.2009.00814.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.6] [Reference Citation Analysis]
82 Zhao F. Biology of Glucose Transport in the Mammary Gland. J Mammary Gland Biol Neoplasia 2014;19:3-17. [DOI: 10.1007/s10911-013-9310-8] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 8.6] [Reference Citation Analysis]
83 He J, Li CF, Lee HJ, Shin DH, Chern YJ, Pereira De Carvalho B, Chan CH. MIG-6 is essential for promoting glucose metabolic reprogramming and tumor growth in triple-negative breast cancer. EMBO Rep 2021;22:e50781. [PMID: 33655623 DOI: 10.15252/embr.202050781] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
84 Nowak N, Kulma A, Gutowicz J. Up-regulation of Key Glycolysis Proteins in Cancer Development. Open Life Sci 2018;13:569-81. [PMID: 33817128 DOI: 10.1515/biol-2018-0068] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
85 Wang J, Ye C, Chen C, Xiong H, Xie B, Zhou J, Chen Y, Zheng S, Wang L. Glucose transporter GLUT1 expression and clinical outcome in solid tumors: a systematic review and meta-analysis. Oncotarget 2017;8:16875-86. [PMID: 28187435 DOI: 10.18632/oncotarget.15171] [Cited by in Crossref: 84] [Cited by in F6Publishing: 81] [Article Influence: 21.0] [Reference Citation Analysis]